These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 9738665

  • 1. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
    Fecho K, Cohen PL.
    J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665
    [Abstract] [Full Text] [Related]

  • 2. Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis.
    Fecho K, Bentley SA, Cohen PL.
    Cell Immunol; 1998 Aug 25; 188(1):19-32. PubMed ID: 9743554
    [Abstract] [Full Text] [Related]

  • 3. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A, Odorico JS.
    Transplantation; 1998 Dec 27; 66(12):1793-801. PubMed ID: 9884278
    [Abstract] [Full Text] [Related]

  • 4. Fas/Fas ligand-mediated apoptosis promotes hypersensitivity pneumonitis in mice by enhancing maturation of dendritic cells.
    Hwang SJ, Kim HS, Chung DH.
    Am J Respir Crit Care Med; 2010 Jun 01; 181(11):1250-61. PubMed ID: 20194815
    [Abstract] [Full Text] [Related]

  • 5. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
    Shimizu M, Fontana A, Takeda Y, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jan 10; 207(1):41-8. PubMed ID: 11161452
    [Abstract] [Full Text] [Related]

  • 6. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.
    Omokaro SO, Desierto MJ, Eckhaus MA, Ellison FM, Chen J, Young NS.
    J Immunol; 2009 Mar 15; 182(6):3414-22. PubMed ID: 19265119
    [Abstract] [Full Text] [Related]

  • 7. Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection.
    Hsu HC, Zhang HG, Song GG, Xie J, Liu D, Yang PA, Fleck M, Wintersberger W, Zhou T, Edwards CK, Mountz JD.
    Arthritis Rheum; 2001 Sep 15; 44(9):2146-59. PubMed ID: 11592380
    [Abstract] [Full Text] [Related]

  • 8. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.
    Fleck M, Zhang HG, Kern ER, Hsu HC, Müller-Ladner U, Mountz JD.
    Arthritis Rheum; 2001 Apr 15; 44(4):964-73. PubMed ID: 11315936
    [Abstract] [Full Text] [Related]

  • 9. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice.
    Hu MS, Schwartzman JD, Yeaman GR, Collins J, Seguin R, Khan IA, Kasper LH.
    Infect Immun; 1999 Feb 15; 67(2):928-35. PubMed ID: 9916110
    [Abstract] [Full Text] [Related]

  • 10. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
    Priceputu E, Rodrigue I, Chrobak P, Poudrier J, Mak TW, Hanna Z, Hu C, Kay DG, Jolicoeur P.
    J Virol; 2005 May 15; 79(10):6377-91. PubMed ID: 15858021
    [Abstract] [Full Text] [Related]

  • 11. Fas- or FasL-deficient mice display an increased sensitivity to nitrobenzene-induced testicular germ cell apoptosis.
    Richburg JH, Nañez A.
    Toxicol Lett; 2003 Mar 20; 139(1):1-10. PubMed ID: 12595153
    [Abstract] [Full Text] [Related]

  • 12. Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity.
    Kamath AB, Camacho I, Nagarkatti PS, Nagarkatti M.
    Toxicol Appl Pharmacol; 1999 Oct 15; 160(2):141-55. PubMed ID: 10527913
    [Abstract] [Full Text] [Related]

  • 13. Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury.
    Du C, Guan Q, Yin Z, Masterson M, Zhong R, Jevnikar AM.
    Transplant Proc; 2003 Nov 15; 35(7):2481-2. PubMed ID: 14611992
    [Abstract] [Full Text] [Related]

  • 14. Immunological and pathological consequences of mutations in both Fas and Fas ligand.
    Weintraub JP, Godfrey V, Wolthusen PA, Cheek RL, Eisenberg RA, Cohen PL.
    Cell Immunol; 1998 May 25; 186(1):8-17. PubMed ID: 9637760
    [Abstract] [Full Text] [Related]

  • 15. Increased retinal neovascularization in Fas ligand-deficient mice.
    Davies MH, Eubanks JP, Powers MR.
    Invest Ophthalmol Vis Sci; 2003 Jul 25; 44(7):3202-10. PubMed ID: 12824272
    [Abstract] [Full Text] [Related]

  • 16. The role of Fas-FasL in the development and treatment of ischemic retinopathy.
    Barreiro R, Schadlu R, Herndon J, Kaplan HJ, Ferguson TA.
    Invest Ophthalmol Vis Sci; 2003 Mar 25; 44(3):1282-6. PubMed ID: 12601060
    [Abstract] [Full Text] [Related]

  • 17. FasL-Fas interactions regulate neovascularization in the cornea.
    Stuart PM, Pan F, Plambeck S, Ferguson TA.
    Invest Ophthalmol Vis Sci; 2003 Jan 25; 44(1):93-8. PubMed ID: 12506060
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
    Wahlsten JL, Gitchell HL, Chan CC, Wiggert B, Caspi RR.
    J Immunol; 2000 Nov 15; 165(10):5480-6. PubMed ID: 11067900
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.
    Weintraub JP, Eisenberg RA, Cohen PL.
    J Immunol; 1997 Oct 15; 159(8):4117-26. PubMed ID: 9379003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.